cytomegalovirus cmv retinitis is the most common cause of vision loss in patients with acquired immunodeficiency syndrome aidscmv retinitis afflicted 25 to 42 of aids patients in the prehighly active antiretroviral therapy haart era with most vision loss due to maculainvolving retinitis or retinal detachmentthe introduction of haart significantly decreased the incidence and severity of cmv retinitisoptimal treatment of cmv retinitis requires a thorough evaluation of the patients immune status and an accurate classification of the retinal lesionswhen retinitis is diagnosed haart therapy should be started or improved and anticmv therapy with oral valganciclovir intravenous ganciclovir foscarnet or cidofovir should be administeredselected patients especially those with zone 1 retinitis may receive intravitreal drug injections or surgical implantation of a sustainedrelease ganciclovir reservoireffective anticmv therapy coupled with haart significantly decreases the incidence of vision loss and improves patient survivalimmune recovery uveitis and retinal detachments are important causes of moderate to severe loss of visioncompared with the early years of the aids epidemic the treatment emphasis in the post haart era has changed from shortterm control of retinitis to longterm preservation of visiondeveloping countries face shortages of health care professionals and inadequate supplies of anticmv and antihiv medicationsintravitreal ganciclovir injections may be the most cost effective strategy to treat cmv retinitis in these areas